Features
So Many Options Coming! What Differences Do We See So Far?
By Cecelia Koetting, OD, FAAO, Jade Coats, OD
VUITY: Considerations in the Prescribing of Presbyopia Drops
By Gina M. Wesley, OD, MS, FAAO
VUITY: Evaluating the New Pharmacologic Presbyopia Treatment Option
By George O. Waring IV, MD, FACS
VUITY: What We Have Learned So Far
Presbyopia-correcting drops may benefit a broad swath of patients.
By Rachael Wruble, OD
Pathogenesis of Presbyopia: A New Understanding of an Age-Old Disease
The Progressive Presbyopia Problem
By ANNMARIE HIPSLEY, DPT, PHD, Max Colbert, MD, MBA
Presbyopia by the Numbers: Who Is Affected by It?
By Komal Patel, OD, Elaine Petry, OD, NATE R. LIGHTHIZER, OD
Gaining the Loyalty of the Presbyopic Emmetrope
By DAVID KADING, OD, FAAO
The Five Pillars of Wellness
Addressing age-related decreases in functional reserve to maintain optimal eye health
By Laura M. Periman, MD
An Evidence Based Guide to Retinal Complications and Miotics
By Cindy Shan, OD, CAROLYN MAJCHER, OD
Customization of Care
Ophthalmology innovator James V. Mazzo discusses refractive IOLs and other opportunities in presbyopia treatment.
By Elizabeth Yeu, MD
Modernizing Monovision
By Elizabeth Yeu, MD
Getting Current on Corneal Allogenic Lenticules
New advances make this presbyopia solution an attractive option
By JOHN D. GELLES, OD, STEVEN A. GREENSTEIN, MD, Peter S. Hersh, MD